Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$51.2

Avg closing price
Price range

5 Richard Pzena Halozyme Therapeutics Trades

The first Halozyme Therapeutics trade was made in Q1 2022. Since then Richard Pzena bought shares one more times and sold shares on three occasions. The investor completely sold their stake between Q1 2023 and Q2 2023.

Avg closing price
Price range
Sold -9.22 Thousand shares Q2 2023
Avg closing price $34.12
Price range $30.28 - $38.74
Sold 36.5% shares (-5.29 Thousand shares) Q1 2023
Avg closing price $46.91
Price range $32.86 - $55.70
New holding (+14.5 Thousand shares) Q4 2022
Avg closing price $51.20
Price range $40.06 - $59.44
Sold -15.7 Thousand shares Q2 2022
Avg closing price $43.25
Price range $37.35 - $48.30
New holding (+15.7 Thousand shares) Q1 2022
Avg closing price $35.62
Price range $31.97 - $41.06

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!